TTK Healthcare logo

TTK Healthcare financials: balance sheet, profit and loss, cash flow

NSE: TTKHLTCAREBSE: 507747DiversifiedSmall Cap

TTK Healthcare Limited · Face value ₹10 · Listed Jan 1987 on BSE, Jul 2010 on NSE
Last close ₹1,022.00up ₹23.50 (2.35%)BSE ₹1,019.15

Share price at the NSE close on 28 Oct 2026. Previous close ₹998.50.

28 Oct: open ₹1,000.10, high ₹1,032.20, low ₹993.00

52-week range of traded prices to 28 Oct 2026
₹735.00Low, 30 Mar 2026₹1,247.00High, 9 Sep 2026
Market cap
₹1,444 Cr1,358th largest listed
P/E
19.53
P/B
1.30
Dividend yield
0.98%
ROE
6.8%
ROCE
2.6%
Debt to equity
0.02
Volume, NSE
4,21049.9% delivered

TTK Healthcare's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.TTK Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
53319Mar 1757818Mar 186282428Mar 196461228Mar 206374618Mar 215994220Mar 2272564026Mar 237536321Mar 248018224Mar 258576624Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
10.2%1.9%7.4%7.4%7.9%4.4%5.5%3.6%4.3%5.0%4.3%3.1%3.6%3.1%3.9%1.9%7.3%8.3%10.2%7.7%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 1.7% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹578 Cr, differs from its quarters added, ₹559 Cr. From the year to Mar 2022, the company's revenue for that year, ₹599 Cr, differs from its quarters added, ₹748 Cr; the company reports a discontinued business.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue857
  2. Materials and goods−403
  3. Employee costs−165
  4. Other expenses−262
  5. Operating profit26
  6. Depreciation−8.8
  7. Other income+72
  8. One-off items−4.1
  9. Finance costs−2.9
  10. Profit before tax83
  11. Tax−17
  12. Net profit66

What the company owns

  • Cash and bank₹633 Cr
  • Plant, investments and other assets₹476 Cr
  • Receivables₹111 Cr
  • Inventory₹109 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,115 Cr
  • Other liabilities₹99 Cr
  • Owed to suppliers₹91 Cr
  • Borrowings₹24 Cr

TTK Healthcare business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them. A segment at a loss has no share of profit.TTK Healthcare segment results by quarter

Revenue by segment

₹857 CrTotal
  • Consumer Products₹241 Cr28.1% of total
  • Protective Devices₹217 Cr25.3% of total
  • Foods₹151 Cr17.6% of total
  • Animal Welfare₹141 Cr16.5% of total
  • Medical Devices₹107 Cr12.5% of total
  • Others₹0 Cr0.0% of total

Profit by segment

  • Consumer Products₹18.4 Cr27.5% of total
  • Foods₹13.4 Cr20.2% of total
  • Animal Welfare₹11.9 Cr17.9% of total
  • Medical Devices₹22.5 Cr33.8% of total
  • Others₹0.4 Cr0.6% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Consumer Products

    Revenue, ₹ crore
    Profit, ₹ crore
  • Protective Devices

    Revenue, ₹ crore
    Profit, ₹ crore
  • Foods

    Revenue, ₹ crore
    Profit, ₹ crore
  • Animal Welfare

    Revenue, ₹ crore
    Profit, ₹ crore
  • Medical Devices

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses628646637797736753801857
Company revenue, as in its results628646637599725753801857
Revenue190181175217241232245241
Revenue growth–−4.6%−3.6%–11.0%−3.7%5.4%−1.5%
Profit3319202324162318
Profit growth–−43.9%8.7%–4.2%−33.0%44.6%−21.8%
Margin17.5%10.3%11.6%10.7%10.0%7.0%9.6%7.6%
Assets3240304047474550
Liabilities4851666466706651
Capital employed−15−12−36−24−20−23−20−1
Revenue10310095133194200207217
Revenue758810298112124133151
Revenue–––99106116126141
Revenue43452751728090107
Revenue11000000
Revenue––––11–––
Revenue–––198––––
Revenue216231238–––––
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.TTK Healthcare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 23 MayMar 2024Mar 2025Mar 2026Filed 30 MayJun 2026Twelve monthsFiled 6 Aug
Revenue from operations533578628646637599725753801857888
494535578617602577694715767831850
Materials and goods bought243242263260252281348338369403416
Employee costs–109131144160103123133151165170
Other expenses–184185214190193223244247262264
Operating profit before depreciation3943502835223137352638
Operating margin7.4%7.4%7.9%4.4%5.5%3.6%4.3%5.0%4.3%3.1%4.3%
Materials, % of revenue–41.8%41.8%40.3%39.5%47.0%48.0%44.9%46.0%47.1%46.8%
Employee costs, % of revenue–18.9%20.8%22.3%25.1%17.2%17.0%17.6%18.8%19.3%19.2%
Other expenses, % of revenue–31.9%29.5%33.1%29.8%32.2%30.7%32.5%30.8%30.6%29.7%
Depreciation and amortisation1215151414131313899
Operating profit after depreciation272735142191924261730
Other income688910164863717271
Finance costs35332353333
Profit before one-off items and tax3030391929226284948798
One-off items––00820014−4−4
Profit before tax30303919372562841088394
1112157−961721271720
Profit from discontinued businesses–––––23595––––
Net profit19182412464264063826674
Other comprehensive income––3−632−2−1−3−21
Total comprehensive income––276504363862786475
Net margin3.6%3.1%3.9%1.9%7.3%––8.3%10.2%7.7%8.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Net margin is left blank for the years to Mar 2022 and Mar 2023: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations199221253311354382416483519
190208237289330362396–478
Materials and goods bought113119134163186190194219229
Operating profit before depreciation9131621242020–40
Operating margin4.4%5.9%6.2%6.9%6.7%5.3%4.7%–7.8%
Depreciation and amortisation2222233–7
Operating profit after depreciation7111420211717–33
Other income343457676
Finance costs222233343
One-off items0––––––––
Profit before tax81316222422202636
Tax26678771013
Net profit1289151614121623
Net margin6.1%3.6%3.6%4.7%4.4%3.7%3.0%3.3%4.4%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 23 MayMar 2024Mar 2025Mar 2026Filed 30 May
2512492953309531,0011,0651,115
Share capital1414141414141414
Reserves2372352813169399871,0511,101
2828182026212424
157172189199211196211206
7111186458
Liabilities going with businesses held for sale–––21––––
4164314945591,1701,2011,2811,329
144134119110104123177111
2722983754241,0661,0771,1041,218
Net debt−97−104−210−253−822−753−762−610
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Filed 23 MayMar 2024Mar 2025Mar 2026Filed 30 May
96.445.0−26.1−4.9−4.0−21.1
76.154.2−10.220.023.8−8.2
41.2−3.9−45.2−15.3−3.1−32.6
Receivables15.9−9.6−22.35.1−4.8−28.8
Inventories1.3−16.11.9−12.5−11.6−0.1
Payables11.112.91.9−8.54.8−15.4
Other working capital12.98.9−26.70.58.511.7
Tax paid20.3−9.2−15.9−25.0−27.8−13.0
Capital spending1.76.511.710.412.85.8
Free cash flow94.738.5−37.8−15.3−16.8−27.0
−77.2−30.533.028.520.151.6
−17.2−9.1−12.4−21.9−18.1−17.6
Dividends paid4.28.514.114.114.114.1
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash2.05.3−5.51.6−2.012.9
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.TTK Healthcare dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 23 MayMar 2024Mar 2025Mar 2026Filed 30 May
Earnings per share₹24.90₹12.86₹17.25₹8.72₹32.87₹29.43₹452.72₹44.47₹57.79₹46.48
Diluted earnings per share₹24.90₹12.86₹17.25₹8.72₹32.87₹29.43₹452.72₹44.47₹57.79₹46.48
Dividend per share₹5.00₹5.00₹5.00₹3.00₹6.00₹10.00₹10.00₹10.00₹10.00₹10.00
Book value per share––₹177.94₹176.21₹208.52₹233.28₹674.71₹708.35₹753.73₹788.98
Dividend payout20.1%38.9%29.0%34.4%18.3%34.0%2.2%22.5%17.3%21.5%
Shareholder yield––––0.6%0.7%1.0%0.7%0.8%1.4%
Market cap at the year end (₹ crore)6128179584496991,1731,4672,0861,6821,045

Ratios

Standalone, years to March.TTK Healthcare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 23 MayMar 2024Mar 2025Mar 2026Filed 30 May
Revenue growth2.7%–8.7%2.8%−1.4%–21.0%3.8%6.5%7.0%
Operating profit growth−2.9%–16.5%−42.9%23.3%–43.6%19.1%−6.7%−24.8%
Net profit growth−14.7%–34.2%−49.5%277.0%–1,438.2%−90.2%29.9%−19.6%
Earnings per share growth––34.1%−49.4%276.9%–1,438.3%−90.2%30.0%−19.6%
––9.7%4.9%17.1%13.3%99.7%6.4%7.9%6.0%
–––−4.8 pts12.2 pts−3.8 pts86.4 pts−93.3 pts1.5 pts−1.9 pts
From the net margin–––−4.9 pts13.9 pts–––1.4 pts−2.0 pts
From asset turnover–––0.0 pts−1.8 pts–––0.1 pts0.1 pts
From borrowing–––0.1 pts0.1 pts–––−0.1 pts0.0 pts
Return on capital employed––12.5%5.0%6.8%2.6%1.9%2.4%2.4%1.5%
Cash conversion––––207.6%108.2%−4.1%−7.9%−4.9%−32.2%
Interest cover8.85.810.34.39.52.93.58.88.05.9
Debt to equity––0.110.110.060.060.030.020.020.02
Receivable days––4743343346424147
Inventory days––771011021028910510798
Payable days––10112114213413111010683
Cash conversion cycle, days––2223−514364363
Working capital days––1013−14−17176259170
Asset turnover––1.511.521.381.140.840.640.650.66
Assets per rupee of net worth––1.651.691.701.691.351.211.201.20
Sales per rupee of plant––6.467.307.477.4710.1910.069.9111.80
Capital spending to depreciation––––0.130.520.910.801.540.66
Plant being built, % of plant in use––1.6%9.9%0.5%0.2%3.9%1.1%0.1%1.9%
Revenue growth, operating profit growth, net profit growth and earnings per share growth are left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. From the net margin, from asset turnover and from borrowing are left blank for the years to Mar 2022, Mar 2023 and Mar 2024: the profit of this year or the year before includes a business the company has discontinued while its revenue does not, so the change in return on equity is not split into margin, turnover and borrowing. Revenue growth and operating profit growth are left blank for the year to Mar 2022: between the two periods the company restated its earlier figures and the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. Net profit growth and earnings per share growth are left blank for the year to Mar 2022: between the two periods the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.0%
Cash from operations against operating profit
−80.8%
Measure10 years5 years3 years
Revenue growth, yearly rate––5.7%
Profit growth, yearly rate––−53.2%
Return on equity, average–26.7%6.8%
Return on capital employed, average–2.2%2.1%
Operating margin, average5.3%4.1%4.1%
Net margin, average––8.7%
Asset turnover, average–0.780.65
Cash conversion cycle, days, average–2947
Interest cover, average6.85.87.6
Debt to equity, average–0.030.02

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−11−30−21
Cash from investing10310052
Cash from financing−79−58−18
Capital spending47296
Dividends paid654214
Shares bought back000
Shares issued for cash000
Borrowings raised600
Borrowings repaid740

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––755444
Altman Z-scorePublished threshold 1.1––5.965.486.406.3412.4113.2513.0113.60
Beneish M-scorePublished threshold −1.78––––−3.33−2.43−1.77−1.97−1.56−2.24
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––5.895.1673.223.315.282.70
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.160.02−0.04−0.14
Receivables growth less revenue growthOur threshold 0 percentage points–––−7.18−20.70−4.5150.89−9.96−1.7415.28
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––30.511.310.44−16.4617.502.89−9.25
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––1.03−0.020.193.3210.18−0.0828.78
Assets under construction, years of additionsOur threshold 2 years of additions–––1.580.040.020.740.050.012.56
Effective tax ratePublished threshold 17.16 per cent35.6839.7537.9236.58−25.3425.4727.5325.3024.6220.45
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−11.501.73−4.37−1.054.73
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 Sep 2026ICRA LimitedFund-based-Cash credit[ICRA]A+Review, Re-affirmStable32.50
22 Sep 2026ICRA LimitedInterchangeable limits-Others[ICRA]A1+Review, Re-affirm16
22 Sep 2026ICRA LimitedUnallocated limits-Unallocated limits[ICRA]A1+Review, Re-affirm0.25
22 Sep 2026ICRA LimitedNon-fund based-Others[ICRA]A1+Review, Re-affirm7.75
29 Sep 2025ICRA LimitedInterchangeable-Others[ICRA]A1+Review, Re-affirm16
29 Sep 2025ICRA LimitedUnallocated-Unallocated[ICRA]A1+Review, Re-affirm0.25
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.